High-frequency variability index-guided remifentanil versus standard care in lower extremity arthroplasty during general anesthesia: A randomized controlled trial

未提供0 个研究点目标入组 50 人开始时间: 2024年6月25日最近更新: 2025年5月28日

适应症

试验速览

暂无简介。

•1.Patients scheduled to undergo unilateral knee or hip replacement under general anesthesia
•2.Patients who are 18 years of age or older at the time of consent (regardless of gender)
•3.Patients scheduled to enter the PACU after surgery
•4.Patients who have received sufficient explanation and informed written consent of their own free will to participate in this study.

•Patients with a history of hypersensitivity to medications to be used during anesthesia
•Patients with a preoperative ASA-PS (American Society of Anesthesiologists Physical Status) of 3 or higher
•Patients who have undergone surgery under general anesthesia at least 1 week before the scheduled surgery
•Patients who have been using narcotic analgesics and antiarrhythmic drugs regularly before the surgery
•Patients with a history of atrial fibrillation
•Patients with a pacemaker
•Patients who are undergoing surgery other than TKAt or THA at the same time.
•Patients who do not understand Japanese and cannot perform NRS evaluation.
•Other patients judged inappropriate as research subjects by the principal investigator and subinvestigators.

Amount of remifentanil used during surgery

NRS(from the time of admission to the PACU to the day after surgery)
Use of supplemental analgesia(from the time of admission to the PACU to the day after surgery)
Complications
Vital signs(during surgery)
HFVI values

发起方

未提供